Touchlight shortlisted for Best Emerging UK Synthetic Biology Company.
Innovate UK funds Touchlight collaboration with Cobra to optimise AAV manufacture
High-quality laboratories established at Touchlight
University College of London collaboration: DBDNA™ for gene therapy
Touchlight awarded Best Emerging UK Biotech Company
Touchlight at Cell & Gene Therapy Europe
Touchlight moves to Hampton
World Vaccine Congress
Join us at World Vaccine Congress, Washington DC (Apr 3-6, 2023).
Dr Lisa Caproni, Head of Vaccine Discovery, will be presenting on the topic “A rapid response platform for nucleic acid vaccines”.
Meet up with us and learn how our doggybone DNA can be used to enable faster, safer and more scalable DNA production than other traditional methods without contamination of the plasmid DNA backbone.